Continued focus on Zika prevention needed Atlanta, GA—(ENEWSPF)—April 4, 2017. Of the 250 pregnant women who had confirmed Zika infection in 2016, 24 – or about 1 in 10 of them – had a fetus or baby with Zika-related birth defects, according to a new Vital Signs report from the[Read More…]
Health and Fitness
Women Experience High Rates of Health Insurance ‘Churn’ Before and After Childbirth
Many women, particularly those covered under Medicaid or the Children’s Health Insurance Program, may lose access to prenatal and postpartum care Boston, MA –(ENEWSPF)–April 4, 2017. A high percentage of women in the U.S. move in and out of health insurance coverage—sometimes referred to as ‘churn’—in the months before and[Read More…]
Maryland General Assembly Adopts Bills to Combat Opioid Epidemic
Legislation Addresses Access to Treatment and Crisis Services, Education, and Public Awareness; Measures Await Final Approval Before Heading to Governor’s Desk MARYLAND—(ENEWSPF)—April 4, 2017. As deaths from drug overdoses increase across the state and nation, the House of Delegates has passed legislation to bolster Maryland’s public health approach to the[Read More…]
Argentina Legalizes Medical Marijuana; Patients Will Receive It Free of Charge
Drug Policy Alliance’s Hannah Hetzer: “It’s heartening to see Argentina prioritize accessibility for patients” Washington, DC—(ENEWSPF)—April 3, 2017. Last week, Argentina legalized medical marijuana, after the Senate unanimously approved a bill that was already passed by the House of Representatives last November. The law establishes a new regulatory framework that[Read More…]
Maternal Tdap Vaccine Highly Effective in Protecting Infants from Pertussis, Study Shows
Elk Grove Village, IL–(ENEWSPF)–April 3, 2017. Vaccinating pregnant women against pertussis was shown to be highly effective in protecting newborn infants against the life-threatening respiratory infection, which is also known as whooping cough, according to a new study to be published in the May 2017 issue of Pediatrics. The maternal[Read More…]
Study Finds Celiac Disease and Anorexia Nervosa Diagnoses Linked
Elk Grove Village, IL–(ENEWSPF)–April 3, 2017. A large-scale study in May 2017 Pediatrics suggests patients diagnosed with celiac disease, an inflammatory digestive disorder triggered by gluten, before age 19 were 4.5 times more likely to have previously been diagnosed with anorexia nervosa. The study (published online April 3) looked at 17,959 women[Read More…]
International Scientific Teams Find Potential Approach Against Parasites
The cyclic peptide ipglycermide binds to an iPGM enzyme, blocking its activity. Bethesda, Maryland–(ENEWSPF)–April 3, 2017. Research teams from the National Institutes of Health and abroad have identified the first inhibitor of an enzyme long thought to be a potential drug target for fighting disease-causing parasites and bacteria. The teams,[Read More…]
CDC Study Finds Flu Vaccine Saves Children’s Lives
Atlanta, GA–(ENEWSPF)–April 3, 2017. A new CDC study published today in Pediatrics is the first of its kind to show that flu vaccination significantly reduced a child’s risk of dying from influenza. The study, which looked at data from four flu seasons between 2010 and 2014, found that flu vaccination[Read More…]
Mylan Provides UPDATE on Meridian Medical Technologies Expanded Voluntary Worldwide Recall of EpiPen® Auto-Injector
Silver Spring, Maryland–(ENEWSPF)–April 3, 2017. Mylan N.V. (NASDAQ, TASE: MYL) today announced that Meridian Medical Technologies, a Pfizer company and Mylan’s manufacturing partner for EpiPen® Auto-Injector, has expanded a voluntary recall of select lots of EpiPen (epinephrine injection, USP) and EpiPen Jr® (epinephrine injection, USP) Auto-Injectors to now include additional[Read More…]
FDA Alerts Consumers of Nationwide Voluntary Recall of EpiPen and EpiPen Jr
Silver Spring, Maryland–(ENEWSPF)–March 31, 2017. The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency treatment of severe allergic reactions. This recall is due to the potential that these[Read More…]
